2000
DOI: 10.4049/jimmunol.165.6.3418
|View full text |Cite
|
Sign up to set email alerts
|

Local Blockade of Allergic Airway Hyperreactivity and Inflammation by the Poxvirus-Derived Pan-CC-Chemokine Inhibitor vCCI

Abstract: Allergen-induced asthma is characterized by chronic pulmonary inflammation, reversible bronchoconstriction, and airway hyperreactivity to provocative stimuli. Multiple CC-chemokines, which are produced by pulmonary tissue in response to local allergen challenge of asthmatic patients or experimentally sensitized rodents, chemoattract leukocytes from the circulation into the lung parenchyma and airway, and may also modify nonchemotactic function. To determine the therapeutic potential of local intrapulmonary CC-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0

Year Published

2002
2002
2010
2010

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 66 publications
(36 citation statements)
references
References 28 publications
0
36
0
Order By: Relevance
“…57 This molecule has been shown to ameliorate some aspects of inflammatory disease. 58 A fifth novel finding of the present study is that MCP-1 enhances migration and the ability of VSMCs from young aortas to invade a Matrigel-coated filter that mimics the extracellular matrix and that after MCP-1 treatment, these features of young VSMCs are indistinguishable from those of early-passage VSMCs from older rats.…”
Section: Discussionmentioning
confidence: 68%
“…57 This molecule has been shown to ameliorate some aspects of inflammatory disease. 58 A fifth novel finding of the present study is that MCP-1 enhances migration and the ability of VSMCs from young aortas to invade a Matrigel-coated filter that mimics the extracellular matrix and that after MCP-1 treatment, these features of young VSMCs are indistinguishable from those of early-passage VSMCs from older rats.…”
Section: Discussionmentioning
confidence: 68%
“…These proteins tightly bind and inhibit the action of CC chemokines but have low or no affinity for chemokines of other subfamilies, making them potent and specific anti-inflammatory agents with demonstrated effectiveness in vivo (18,25). An extensive binding study with vaccinia vCCI using Ͼ80 chemokines from several organisms revealed 26 CC chemokines that bind with high affinity, including 13 human chemokines, such as MCP-1 (monocyte chemoattractant protein 1), MIP-1␣, MIP-1␤, and RANTES (26).…”
Section: Resultsmentioning
confidence: 99%
“…Although some CKBPs interact with a very broad spectrum of chemokines across several chemokine subfamilies, the viral CC chemokine inhibitor (vCCI) proteins (previously called T1͞35 kDa, also classified as type II CKBPs) produced by leporipoxviruses and orthopoxviruses bind selectively to members of the CC subfamily (16,17). vCCI proteins have been shown to be potent inhibitors of chemokine action in vitro (17) and effective anti-inflammatory agents in vivo (18). Sequence alignment of vCCI proteins from five orthopoxvirus members [rabbitpox, cowpox, vaccinia-Lister, vaccinia-Copenhagen, and variola poxvirus (the causative agent of human smallpox)] shows at least 80% identity (Fig.…”
mentioning
confidence: 99%
“…It has been described that vCKBP binds with high affinity to virtually all known CC chemokines, but not CXC chemokines, blocking their biological activity by competitive inhibition of chemokine interaction with their respective cellular receptors on target cells in vitro as well as in in vivo inflammatory reactions (16,17,20,21). The concomitant treatment with vCKBP significantly inhibited the LPS-induced ␥␦ T cell influx into mice pleural cavities observed 24 h after stimulation (Fig.…”
Section: Chemokine Neutralization By Vckbp Inhibits Lps-induced ␥␦mentioning
confidence: 95%